Related posts
Most Anticipated Earnings: BLDP-T, BOS-T and more Canadian Companies Reporting Earnings this Week (May 06-10)TSX slips during quiet MondayStocks climb, oil sinksThis summary was created by AI, based on 18 opinions in the last 12 months.
Converge Technology Solutions (CTS-T) has faced challenges such as missed quarters, failed attempts to sell the company, and a shift from acquisitions to focusing on operations. However, it has shown positive momentum in terms of revenue growth, free cash flow, and a healthy balance sheet. There is some uncertainty regarding its profitability and future prospects, but it is trading at a relatively cheap valuation and is seen as a potential takeover target. Overall, the stock has faced setbacks but also has potential for growth and recovery.
We continue to like CTS, and although its recent momentum has not been favourable, we believe its long-term value is still in play. It pays a small yield of 1.4%, analysts expect decent forward sales and earnings growth, albeit slightly lumpy, but its valuation reflects this, at 7X forward earnings. Its valuation is cheap, its debt levels are fine, and its free cash flow is impressive. While recent momentum has not been great, we continue to believe its valuation will re-rate as its fundamentals continue to improve.
Unlock Premium - Try 5i Free
Will see strength in the tech sector going forward. Would recommend buying if the chart begins to turn. Seeing upside in the stock.
It's done OK, but not as great as the big names. 12-month target is $6.55. Pretty widely held. Removed from the TSX Composite, so that dragged it out of some portfolios. Buy in thirds here at $4.70, $4.50, and $4.25.
Fundamentally, the story hasn't changed. Market's gone through a correction. Very inexpensive. Good play on AI, as purchases in that area are made through a company like this. Be patient. Low valuation, raised dividend, buying back stock, you'll be fine.
Hired some new expertise. 12-month price target around $6.25. If it breaks through that, there's nothing between $6.75 and $10. He's watching carefully.
Great rebound this year. Acquisition spree, overpaid, grandiose ambitions. New CFO has transformed operations. Outlook very solid. Very strong shape financially. Buying back shares, initiated dividend. Cheap at 8-9x earnings. More upside.
It missed a couple of quarters and has undergone a strategic review but has not been sold. It has stopped doing acquisitions and is focusing on operations. It has a new CFO who has a good reputation. It looks cheap, is executing, and is a potential takeover. He is looking at an $8 target.
Way better tech investments to make. Tried to sell company, didn't go anywhere, stock collapsed. Low-margin business.
Recent breakout good for momentum investors. Not at all time highs yes. Watching closely. Fairly stable up trend. Now a good time to buy.
Had a big move technically. Be careful, as it looks as though it's going for a head and shoulder pattern. Under 8x 2024 numbers, growing 19%. TSX is brightening, as long as the economy stays like this. Good one to buy.
Unlike Nvidia, CTS trades at 5.5x PE. Has a lot of upside where profits are growing faster than revenues.
(Analysts’ price target is $6.66)CTS had a good update, but we would like to see the final year profit numbers and would also like to see more quarters to ensure a positive trend has been established. We are comfortable with it as a HOLD but less so as an ADD. On the TFSA question there is no answer that suits everyone. We would suggest 8 to 12.
Unlock Premium - Try 5i Free
Doesn't follow it closely. Gross margins are 15% max. They were growing by acquisition until higher interest rates paused that. Organic growth is around 5% at best. It doesn't deserve a high valuation. They didn't attract a high enough offer to be bought out.
In 2020/21 it was growing rapidly but has pulled back from its high of $12. There were some missteps and it missed a couple of quarters. However in the past 6 to 12 months it has started focusing on integrating the companies they bought and not buying new ones. It is also focusing on cost control and cross selling. It is doing the right things now but it will take some time to expand their margins.
Converge Technology Solutions is a Canadian stock, trading under the symbol CTS-T on the Toronto Stock Exchange (CTS-CT). It is usually referred to as TSX:CTS or CTS-T
In the last year, 16 stock analysts published opinions about CTS-T. 9 analysts recommended to BUY the stock. 4 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Converge Technology Solutions.
Converge Technology Solutions was recommended as a Top Pick by on . Read the latest stock experts ratings for Converge Technology Solutions.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
16 stock analysts on Stockchase covered Converge Technology Solutions In the last year. It is a trending stock that is worth watching.
On 2024-07-26, Converge Technology Solutions (CTS-T) stock closed at a price of $4.27.
Owns small amount of shares. M&A has paused lately. Strategic review didn't go well. Time will tell whether business will continue to perform. Wait and see type of stock.